← Eichor
Condition: Cocaine Use Disorder Synced from ClinicalTrials.gov · July 28, 2026

Recruiting studies: Cocaine Use Disorder

Studies currently listed as recruiting on the public registry for this search term. Each page explains the study in plain language, with locations and the study team's contact details. Clinicians: generate a printable list for your patient →

Transcranial Direct Current Stimulation (tDCS) for Treatment of Cocaine Use Disorder
NA · 1 location(s) · Icahn School of Medicine at Mount Sinai · NCT07318480
Screening, Evaluation and Assessment (SEA) Protocol at the NIDA IRP
Phase N/A · 1 location(s) · National Institute on Drug Abuse (NIDA) · NCT06552741
Cocaine and Pentoxifylline (BED IN 47)
EARLY_Phase 1 · 1 location(s) · William Stoops · NCT07086794
Impact of Cocaine Use and Withdrawal on Sleep
Phase N/A · 3 location(s) · Hôpital le Vinatier · NCT07119567
Aberrant Synaptic Plasticity in Cocaine Use Disorder: A 11C-UCB-J PET Study
Phase N/A · 1 location(s) · Yale University · NCT04721418
Evaluation Of Semaglutide in Adults With Cocaine Use Disorder With and Without HIV
Phase 2 · 2 location(s) · University of Maryland, Baltimore · NCT06691243
Cocaine Cue-reactivity Incubation Study
NA · 1 location(s) · Icahn School of Medicine at Mount Sinai · NCT07091877
Web-based Alcohol- or Cocaine-specific Inhibition Training in Adolescents and Young Adults With Substance Use Disorder
NA · 1 location(s) · University of Bern · NCT07071779
Ketamine and Neurofeedback-Training: Effects on Neuroplasticity in Cocaine Addiction
Phase 2 · 1 location(s) · Dr. med. Marcus Herdener · NCT06125054
Transdermal Rotigotine as Adjunct to Behavioral Therapy for Cocaine Use Disorder
Phase 2 · 1 location(s) · Virginia Commonwealth University · NCT05886582
Encouraging Abstinence Behavior in a Drug Epidemic: Optimizing Dynamic Incentives
NA · 2 location(s) · Wake Forest University Health Sciences · NCT04927143
CRACK-TARGET 1: Descriptive Study of Observed Behavioral Sensitization and Expectations
NA · 2 location(s) · Assistance Publique - Hôpitaux de Paris · NCT06050304
Efficacy and Safety of Sustained-release Dexamphetamine in Patients With Moderate to Severe Cocaine Use Disorder
Phase 2 · 1 location(s) · Parnassia Addiction Research Centre · NCT05529927
Effect of HF rTMS on Serum BDNF in Cocaine Use Disorder
NA · 1 location(s) · Instituto Nacional de Psiquiatría Dr. Ramón de la Fuente · NCT06189690
Repurposing Semaglutide for the Treatment of Cocaine Use Disorder
Phase 2 · 1 location(s) · The University of Texas Health Science Center, Houston · NCT07227948
Identifying Electrophysiological Targets for Transcranial Magnetic Stimulation in Cocaine Use Disorder
NA · 1 location(s) · The University of Texas Health Science Center, Houston · NCT05986578
Smartphone Services for Stimulant Use Disorder
NA · 1 location(s) · DynamiCare Health · NCT07092059
Role of Pavlovian Mechanisms for Control Over Substance Use
Phase N/A · 1 location(s) · Technische Universität Dresden · NCT06701487
A Trial Of Approach Bias Modification Training During Treatment For Cocaine Use Disorder
NA · 1 location(s) · ASST Fatebenefratelli Sacco · NCT07033416
Harm Reduction Services
NA · 3 location(s) · NYU Langone Health · NCT05776316
Contingency Management Plus Deep Transcranial Magnetic Stimulation for the Treatment of Cocaine Use Disorder
NA · 1 location(s) · The University of Texas Health Science Center, Houston · NCT07490600
[C-11]NPA PET-amphetamine in Cocaine Use Disorders
EARLY_Phase 1 · 1 location(s) · Rajesh Narendran · NCT05011760
Imaging CRF X NOP Interactions in CUD
EARLY_Phase 1 · 1 location(s) · Rajesh Narendran · NCT05008146
Orexin Receptor Antagonism and Sleep in Stimulant Use Disorder
Phase 2 · 1 location(s) · The University of Texas Health Science Center, Houston · NCT06444256
Efficacy of Clonidine in Reducing Craving in Inpatients With Cocaine and Crack Use Disorder
Phase 4 · 1 location(s) · University of Sao Paulo General Hospital · NCT07313371
Look up another condition
Patient organization or foundation? You can brand this page for your community — your logo, your resources, same honest registry data, kept current daily. Ask about branding →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.